Have a personal or library account? Click to login
The Potential of Biotechnology Investments in Selected Eastern European Countries: Lost Chances Cover

The Potential of Biotechnology Investments in Selected Eastern European Countries: Lost Chances

Business Systems Research Journal
Volume 7 (2016): Issue 1 (March 2016)
By:
Open Access
|May 2016

References

  1. 1. Adelman, D. & Holman, C., (2009). “Misplaced Fears in the Legislative Battle Over Affordable Biotech Drugs”. Idea, Vol.50 No.4, pp.565–591.
    Search in Google Scholar
  2. 2. AWA, (2012). “Lifescience Zurich Booklet”, Zurich.
    Search in Google Scholar
  3. 3. Bloomberg, (2014). “Bloomberg”. visual data.
    Search in Google Scholar
  4. 4. Boschma, R., Heimeriks, G. &amp; Balland, P.-A., (2014). “Scientific knowledge dynamics and relatedness in biotech cities”. Research Policy, Vol.43 No.1, pp.107–114.<dgdoi:pub-id xmlns:dgdoi="http://degruyter.com/resources/doi-from-crossref" pub-id-type="doi"><a href="https://doi.org/10.1016/j.respol.2013.07.009" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1016/j.respol.2013.07.009</a></dgdoi:pub-id>
    Search in Google Scholar
  5. 5. Brada, J.C., Kutan, A.M. &amp; Yigit, T.M., (2006). “The effects of transition and political instability on foreign direct investment inflows.”. The Economics of Transition, Vol.14 No.4, pp.649–680.<dgdoi:pub-id xmlns:dgdoi="http://degruyter.com/resources/doi-from-crossref" pub-id-type="doi"><a href="https://doi.org/10.1111/j.1468-0351.2006.00272.x" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1111/j.1468-0351.2006.00272.x</a></dgdoi:pub-id>
    Search in Google Scholar
  6. 6. Coan, T.D. &amp; Ron, E., (2001). “Generic Biologics: The Next Frontier”, London.
    Search in Google Scholar
  7. 7. Consortium, S.G. et al., (2008). “Protein production and purification”., Vol.5 No.2.
    Search in Google Scholar
  8. 8. Debackere, K. &amp; Veugelers, R., (2005). “The role of academic technology transfer organizations in improving industry science links”. Research Policy, Vol.34 No.3, pp.321–342.<dgdoi:pub-id xmlns:dgdoi="http://degruyter.com/resources/doi-from-crossref" pub-id-type="doi"><a href="https://doi.org/10.1016/j.respol.2004.12.003" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1016/j.respol.2004.12.003</a></dgdoi:pub-id>
    Search in Google Scholar
  9. 9. EAER, (2014). “Swiss Biotech Report 2014”,
    Search in Google Scholar
  10. 10. Van Epps, H.L., (2006). “Singapore’s multibillion dollar gamble.”. The Journal of experimental medicine, Vol.203 No.5, pp.1139–42.<dgdoi:pub-id xmlns:dgdoi="http://degruyter.com/resources/doi-from-crossref" pub-id-type="doi"><a href="https://doi.org/10.1084/jem.20060895" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1084/jem.20060895</a></dgdoi:pub-id>
    Search in Google Scholar
  11. 11. Ereky, K., (1919). “Biotechnologie der Fleisch-, Fett-, und Milcherzeugung im landwirtschaftlichen Grossbetriebe: für naturwissenschaftlich gebildete Landwirte verfasst”, Berlin: P. Parey.
    Search in Google Scholar
  12. 12. Ernst &amp; Young, (2013). “Beyond borders: global biotechnology report 2013”. Beyond borders, No.27.
    Search in Google Scholar
  13. 13. Essendorfer, S., Diaz-Rainey, I. &amp; Falta, M., (2015). “Creative destruction in Wall Street’s technological arms race: Evidence from patent dataNo Title”. Technological Forecasting and Social Change.<dgdoi:pub-id xmlns:dgdoi="http://degruyter.com/resources/doi-from-crossref" pub-id-type="doi"><a href="https://doi.org/10.1016/j.techfore.2014.11.012" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1016/j.techfore.2014.11.012</a></dgdoi:pub-id>
    Search in Google Scholar
  14. 14. Fári, M.G. &amp; Kralovánszky, U.P., (2006). “The founding father of biotechnology: Károly (Karl) Ereky”. International Journal of Horticultural Science, Vol.12 No.1, pp.9–12.<dgdoi:pub-id xmlns:dgdoi="http://degruyter.com/resources/doi-from-crossref" pub-id-type="doi"><a href="https://doi.org/10.31421/IJHS/12/1/615" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.31421/IJHS/12/1/615</a></dgdoi:pub-id>
    Search in Google Scholar
  15. 15. Farrell, D., (2005). “Offshoring: Value creation through economic change”. Journal of Management Studies, Vol.42 No.3, pp.675–683.<dgdoi:pub-id xmlns:dgdoi="http://degruyter.com/resources/doi-from-crossref" pub-id-type="doi"><a href="https://doi.org/10.1111/j.1467-6486.2005.00513.x" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1111/j.1467-6486.2005.00513.x</a></dgdoi:pub-id>
    Search in Google Scholar
  16. 16. Gerstein, M.B. et al., (2007). “What is a gene, post-ENCODE? History and updated definition.”. Genome research, Vol.17 No.6, pp.669–81.<dgdoi:pub-id xmlns:dgdoi="http://degruyter.com/resources/doi-from-crossref" pub-id-type="doi"><a href="https://doi.org/10.1101/gr.6339607" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1101/gr.6339607</a></dgdoi:pub-id>
    Search in Google Scholar
  17. 17. Glick, J.L., (2008). “Biotechnology business models work: Evidence from the pharmaceutical marketplace”. Journal of Commercial Biotechnology, Vol.14 No.2, pp.106–117.<dgdoi:pub-id xmlns:dgdoi="http://degruyter.com/resources/doi-from-crossref" pub-id-type="doi"><a href="https://doi.org/10.1057/palgrave.jcb.3050085" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1057/palgrave.jcb.3050085</a></dgdoi:pub-id>
    Search in Google Scholar
  18. 18. Gregersen, N. et al., (2006). “Protein misfolding and human disease.”. Annual review of genomics and human genetics, Vol.7, pp.103–24.<dgdoi:pub-id xmlns:dgdoi="http://degruyter.com/resources/doi-from-crossref" pub-id-type="doi"><a href="https://doi.org/10.1146/annurev.genom.7.080505.115737" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1146/annurev.genom.7.080505.115737</a></dgdoi:pub-id>
    Search in Google Scholar
  19. 19. Grullon, G., Lyandres, E. &amp; Zhdanov, A., (2012). “Real Options, Volatility, and Stock Returns”. Journal of Finance, Vol.67 No.4, pp.1499–1537.<dgdoi:pub-id xmlns:dgdoi="http://degruyter.com/resources/doi-from-crossref" pub-id-type="doi"><a href="https://doi.org/10.1111/j.1540-6261.2012.01754.x" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1111/j.1540-6261.2012.01754.x</a></dgdoi:pub-id>
    Search in Google Scholar
  20. 20. Hollanders, H. &amp; Es-Sadki, N., (2014). “Innovation Union Scoreboard 2014”, Maastricht.
    Search in Google Scholar
  21. 21. Hulse, J.H., (2004). “Biotechnologies: past history, present state and future prospects”. Trends in Food Science &amp; Technology, Vol.15 No.1, pp.3–18.<dgdoi:pub-id xmlns:dgdoi="http://degruyter.com/resources/doi-from-crossref" pub-id-type="doi"><a href="https://doi.org/10.1016/S0924-2244(03)00157-2" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1016/S0924-2244(03)00157-2</a></dgdoi:pub-id>
    Search in Google Scholar
  22. 22. IMD, (2013). “International Institute for Management Development”. world competitiveness online.
    Search in Google Scholar
  23. 23. JLL, (2012). “NoLife Sciences Outlook Switzerland. 2012”, Zurich.
    Search in Google Scholar
  24. 24. Junkunc, M.T., (2007). “Managing radical innovation: The importance of specialized knowledge in the biotech revolution”. Journal of Business Venturing, Vol.22 No.3, pp.388–411.<dgdoi:pub-id xmlns:dgdoi="http://degruyter.com/resources/doi-from-crossref" pub-id-type="doi"><a href="https://doi.org/10.1016/j.jbusvent.2006.04.004" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1016/j.jbusvent.2006.04.004</a></dgdoi:pub-id>
    Search in Google Scholar
  25. 25. Kim, W.C. &amp; Mauborgne, R., (2004). “Blue ocean strategy”. Harvard Business Review, Vol.82 No.10, pp.76–84.
    Search in Google Scholar
  26. 26. Kishore, G.M. &amp; Shewmaker, C., (1999). “Biotechnology: Enhancing human nutrition in developing and developed worlds”. Proceedings of the National Academy of Sciences, Vol.96 No.11, pp.5968–5972.<dgdoi:pub-id xmlns:dgdoi="http://degruyter.com/resources/doi-from-crossref" pub-id-type="doi"><a href="https://doi.org/10.1073/pnas.96.11.5968" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1073/pnas.96.11.5968</a></dgdoi:pub-id>
    Search in Google Scholar
  27. 27. Kochanova, A., (2012). “The Impact of Bribery on Firm Performance: Evidence from Central and Eastern European Countries”, The Center for Economic Research and Graduate Education - Economic Institute, Prague.<dgdoi:pub-id xmlns:dgdoi="http://degruyter.com/resources/doi-from-crossref" pub-id-type="doi"><a href="https://doi.org/10.2139/ssrn.2191094" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.2139/ssrn.2191094</a></dgdoi:pub-id>
    Search in Google Scholar
  28. 28. Kogan, L., Papanikolaou, D. &amp; Stoffman, N., (2015). “Winners and Losers: Creative Destruction and the Stock Market”,
    Search in Google Scholar
  29. 29. Kolev, A. &amp; Saget, C., (2005). “Understanding youth labour market disadvantage: Evidence from south-east Europe”. International Labour Review, Vol.144 No.2, pp.161–187.<dgdoi:pub-id xmlns:dgdoi="http://degruyter.com/resources/doi-from-crossref" pub-id-type="doi"><a href="https://doi.org/10.1111/j.1564-913X.2005.tb00564.x" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1111/j.1564-913X.2005.tb00564.x</a></dgdoi:pub-id>
    Search in Google Scholar
  30. 30. Kozlowski, J., Radosevic, S. &amp; Ircha, D., (1999). “History matters: The inherited disciplinary structure of the post-communist science in countries of central and eastern Europe and its restructuring”. Scientometrics, Vol.45 No.1, pp.137–166.<dgdoi:pub-id xmlns:dgdoi="http://degruyter.com/resources/doi-from-crossref" pub-id-type="doi"><a href="https://doi.org/10.1007/BF02458473" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1007/BF02458473</a></dgdoi:pub-id>
    Search in Google Scholar
  31. 31. Lim, L.P.L. &amp; Gregory, M.J., (2004). “Singapore’s biomedical science sector development strategy: Is it sustainable?”. Journal of Commercial Biotechnology, Vol.10 No.4, pp.352–362.<dgdoi:pub-id xmlns:dgdoi="http://degruyter.com/resources/doi-from-crossref" pub-id-type="doi"><a href="https://doi.org/10.1057/palgrave.jcb.3040093" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1057/palgrave.jcb.3040093</a></dgdoi:pub-id>
    Search in Google Scholar
  32. 32. Meyer, M., (2003). “Academic entrepreneurs or entrepreneurial academics? research-based ventures and public support mechanisms”.<dgdoi:pub-id xmlns:dgdoi="http://degruyter.com/resources/doi-from-crossref" pub-id-type="doi"><a href="https://doi.org/10.1111/1467-9310.00286" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1111/1467-9310.00286</a></dgdoi:pub-id>
    Search in Google Scholar
  33. 33. MLSC, (2014). “Massachusetts Life Sciences Center”.
    Search in Google Scholar
  34. 34. Mungiu-pippidi, A., (2014). “The Transformative Power of Europe Revisited”. Journal of Democracy, Vol.25 No.1, pp.20–32.<dgdoi:pub-id xmlns:dgdoi="http://degruyter.com/resources/doi-from-crossref" pub-id-type="doi"><a href="https://doi.org/10.1353/jod.2014.0003" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1353/jod.2014.0003</a></dgdoi:pub-id>
    Search in Google Scholar
  35. 35. NCES, (2014). “National Center for Education Statistics”.
    Search in Google Scholar
  36. 36. Nicholson, S., Danzon, P. &amp; McCullough, J., (2002). “Biotech-Pharmaceutical Alliances as a Signal of Asset and Firm Quality”, Cambridge, MA.<dgdoi:pub-id xmlns:dgdoi="http://degruyter.com/resources/doi-from-crossref" pub-id-type="doi"><a href="https://doi.org/10.3386/w9007" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.3386/w9007</a></dgdoi:pub-id>
    Search in Google Scholar
  37. 37. OECD, (2014). “Defining biotechnology”.
    Search in Google Scholar
  38. 38. OECD, (2013). “Employment and Labour Markets: Key Tables from OECD”, OECD Productivity Statistics.
    Search in Google Scholar
  39. 39. Owen-Smith, J. &amp; Powell, W.W., (2006). “Accounting for Emergence and Novelty in Boston and Bay Area Biotechnology”. In P. Braunerhjelm &amp; M. P. Feldman, eds. Cluster Genesis: Technology-Based Industrial Development. Oxford Scholarship, pp. 1–39.<dgdoi:pub-id xmlns:dgdoi="http://degruyter.com/resources/doi-from-crossref" pub-id-type="doi"><a href="https://doi.org/10.1093/acprof:oso/9780199207183.003.0004" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1093/acprof:oso/9780199207183.003.0004</a></dgdoi:pub-id>
    Search in Google Scholar
  40. 40. Pearson, H., (2006). “Genetics: what is a gene?”. Nature, Vol.441 No.7092, pp.398–401.
    Search in Google Scholar
  41. 41. Rader, R.A., (2008). “(Re)defining biopharmaceutical.”. Nature biotechnology, Vol.26 No.7, pp.743–51.<dgdoi:pub-id xmlns:dgdoi="http://degruyter.com/resources/doi-from-crossref" pub-id-type="doi"><a href="https://doi.org/10.1038/nbt0708-743" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1038/nbt0708-743</a></dgdoi:pub-id>
    Search in Google Scholar
  42. 42. Radosevic, S. &amp; Auriol, L., (1999). “Patterns of restructuring in research, development and innovation activities in central and eastern European countries: an analysis based on S&amp;T indicators”. Research Policy, Vol.28 No.4, pp.351–376.<dgdoi:pub-id xmlns:dgdoi="http://degruyter.com/resources/doi-from-crossref" pub-id-type="doi"><a href="https://doi.org/10.1016/S0048-7333(98)00124-3" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1016/S0048-7333(98)00124-3</a></dgdoi:pub-id>
    Search in Google Scholar
  43. 43. Rossi, M., Tarba, S.Y. &amp; Raviv, A., (2013). “Mergers and acquisitions in the hightech industry: a literature review”. International Journal of Organizational Analysis, Vol.21 No.1, pp.66–82.<dgdoi:pub-id xmlns:dgdoi="http://degruyter.com/resources/doi-from-crossref" pub-id-type="doi"><a href="https://doi.org/10.1108/19348831311322542" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1108/19348831311322542</a></dgdoi:pub-id>
    Search in Google Scholar
  44. 44. Schafer, S., (2011). “Top 20 Countries in ALL FIELDS”. Essential Science Indicators.
    Search in Google Scholar
  45. 45. Schwab, K. &amp; Sala-i-Martín, X., (2014). “The Global Competitiveness Report”,
    Search in Google Scholar
  46. 46. Senker, J., Enzing, C. &amp; Reiss, T., (2012). “Biotechnology in Central and Eastern Europe: An overview of performance and policy system”. In Exploring Central and Eastern Europe’s Biotechnology Landscape. pp. 13–35.<dgdoi:pub-id xmlns:dgdoi="http://degruyter.com/resources/doi-from-crossref" pub-id-type="doi"><a href="https://doi.org/10.1007/978-90-481-9784-2_2" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1007/978-90-481-9784-2_2</a></dgdoi:pub-id>
    Search in Google Scholar
  47. 47. ShanghaiRanking, (2014). “Academic Ranking of World Universities 2013”.
    Search in Google Scholar
  48. 48. UNSD, (2011). “Expert Group discusses future work on classifications”, New York.
    Search in Google Scholar
  49. 49. Waldmann, T. a, (2003). “Immunotherapy: past, present and future.”. Nature medicine, Vol.9 No.3, pp.269–77.<dgdoi:pub-id xmlns:dgdoi="http://degruyter.com/resources/doi-from-crossref" pub-id-type="doi"><a href="https://doi.org/10.1038/nm0303-269" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1038/nm0303-269</a></dgdoi:pub-id>
    Search in Google Scholar
  50. 50. Walsh, G., (2014). “Biopharmaceutical benchmarks 2014”. Nature biotechnology, Vol.32 No.7, pp.992–1000.<dgdoi:pub-id xmlns:dgdoi="http://degruyter.com/resources/doi-from-crossref" pub-id-type="doi"><a href="https://doi.org/10.1038/nbt.3040" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1038/nbt.3040</a></dgdoi:pub-id>
    Search in Google Scholar
  51. 51. WEF, (2014). “Labor market efficiency”. In The Global Competitiveness Report 2013-2014. World Economic Forum, p. 10.
    Search in Google Scholar
  52. 52. Wolfe, R.M., (2012). “Business R &amp; D Performed in the United States Cost $ 291 Billion in 2008 and $ 282 Billion in 2009”,
    Search in Google Scholar
  53. 53. Wong, P.-K., Ho, Y.-P. &amp; Singh, A., (2009). “Industrial Cluster Development and Innovation in Singapore”. In A. Kuchiki &amp; M. Tsuji, eds. From Agglomeration to Innovation. IDE-JETRO, pp. 50–116.
    Search in Google Scholar
  54. 54. WorldBank, (2014)(a). “GDP growth (annual %)”. World Development Indicators.
    Search in Google Scholar
  55. 55. WorldBank, (2014)(b). “Research and development expenditure (% of GDP)”. World Development Indicators.
    Search in Google Scholar
  56. 56. WorldBank, (2014)(c). “Scientific and technical journal articles”. World Development Indicators.
    Search in Google Scholar
  57. 57. Wurm, F.M., (2004). “Production of recombinant protein therapeutics in cultivated mammalian cells.”. Nature biotechnology, Vol.22 No.11, pp.1393–8.<dgdoi:pub-id xmlns:dgdoi="http://degruyter.com/resources/doi-from-crossref" pub-id-type="doi"><a href="https://doi.org/10.1038/nbt1026" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1038/nbt1026</a></dgdoi:pub-id>
    Search in Google Scholar
  58. 58. Yamaner, M., (2012). “Federal Funds for Research and Development: Fiscal Year 2009-11”,
    Search in Google Scholar
  59. 59. Zürcher, J., (2005). “Swiss Biotech Report 2005”, Winterthur.
    Search in Google Scholar
DOI: https://doi.org/10.1515/bsrj-2016-0002 | Journal eISSN: 1847-9375 | Journal ISSN: 1847-8344
Journal RSS Feed
Language: English
Page range: 16 - 34
Submitted on: May 7, 2015
Accepted on: Sep 13, 2015
Published on: May 28, 2016
Published by: IRENET - Society for Advancing Innovation and Research in Economy
In partnership with: Paradigm Publishing Services
Publication frequency: 2 times per year
Keywords:
biotechnology,
investment,
research and development,
transition countries,
Eastern Europe
Related subjects:
Business and economics,
Business management,
Management, organization, corporate governance,
Business management, other,
Mathematics and statistics for economists,
Mathematics

© 2016 Patrik Vida, published by IRENET - Society for Advancing Innovation and Research in Economy
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

Previous articleVolume 7 (2016): Issue 1 (March 2016)Next article